LENTI-D
Live / Registered — Registered — Section 71 accepted (as of 07 Feb 2025)
What this means for you
Registered since 13 Nov 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79232103
- Registration number
- 5603940
- Mark type
- Stylized text
- Filed
- 15 Mar 2018
- Published for opposition
- 28 Aug 2018
- Registered
- 13 Nov 2018
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of genetic diseases
Owner
- Genetix Biotherapeutics, Inc., US
- bluebird bio, Inc., Somerville, DE, US
- bluebird bio (UK) Ltd., GB
- bluebird bio (UK) Ltd., GB
- bluebird bio (UK) Ltd., GB
Prosecution history
- 18 Dec 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 13 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 07 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 30 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Sept 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 May 2024 — TEAS SECTION 71 RECEIVED
- 23 Dec 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 13 Nov 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 26 Aug 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 15 Nov 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Oct 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 13 Jun 2019 — CHANGE OF OWNER RECEIVED FROM IB
- 16 Mar 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Feb 2019 — FINAL DISPOSITION NOTICE SENT TO IB